Table of Contents
- Executive Summary
- Strategic Considerations
- Stakeholder Implications
- Overview
- Schedule of Patent Expirations
- Barriers to Generics Competition
- Payers' Support for Generics
- United States
- Europe
- Japan
- Outlook and Implications for the Pharmaceutical Industry
Tables
- 1. Blockbuster Prescription Drugs, 2006
- 2. Patent Expiration Timetable for 2006 Blockbuster Drugs
- 3. Total Sales in the Seven Major Markets of Leading Manufacturers'
Blockbuster Drugs That Will Lose Patent Protection from 2007 to 2017
- 4. U.S. Employers' Views on Strategies to Increase Prescription Drug
Benefi t Value, 2005
Figures
- 1. Total Sales in the United States of Blockbuster Drugs That Lose Patent
Protection in a Given Year from 2007 to 2021
- 2. Total Sales in France of Blockbuster Drugs That Lose Patent Protection
in a Given Year from 2007 to 2019
- 3. Total Sales in Germany of Blockbuster Drugs That Lose Patent Protection
in a Given Year from 2007 to 2019
- 4. Total Sales in Italy of Blockbuster Drugs That Lose Patent Protection
in a Given Year from 2007 to 2019
- 5. Total Sales in Spain of Blockbuster Drugs That Lose Patent Protection
in a Given Year from 2007 to 2019
- 6. Total Sales in the United Kingdom of Blockbuster Drugs That Lose Patent
Protection in a Given Year from 2007 to 2019
- 7. Total Sales in Japan of Blockbuster Drugs That Lose Patent Protection
in a Given Year from 2007 to 2018
- 8. Total Sales in Seven Major Markets of Blockbuster Drugs That Lose
Patent Protection in a Given Year from 2007 to 2019
|
Related Report
|
View Cart
